The first biologic treatment for psoriasis, Amevive (Am-uh-veev), is now approved and on the market
December 2004
The first biologic treatment for psoriasis, Amevive (Am-uh-veev), is now approved and on the market.
Amevive (alefacept) is an immunosuppressant. It inhibits the T-cells that contribute to psoriasis.
It's given IM once weekly for 12 weeks...followed by a 12-week break. Some patients will be taught to self-inject IM at home.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive